Pfizer: Omicron booster strong against BQ.1.1



Pfizer Inc. and BioNTech SE announced on Friday that their bivalent jab aimed at the Omicron strain of COVID-19 shows a higher success rate against the emerging sub-variant BQ.1.1 in older people comp…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento